CYP3A4 is a vitamin D-24- and 25-hydroxylase: Analysis of structure function by site-directed mutagenesis

被引:76
作者
Gupta, RP
He, YA
Patrick, KS
Halpert, JR
Bell, NH
机构
[1] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
[3] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
D O I
10.1210/jc.2004-0966
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies were performed to identify the microsomal enzyme that 24-hydroxylates vitamin D, whether 25-hydroxylation occurs, and structure function of the enzyme. Sixteen hepatic recombinant microsomal cytochrome P450 enzymes expressed in baculovirus-infected insect cells were screened for 24-hydroxylase activity. CYP3A4, a vitamin D-25-hydroxylase, and CYP1A1 had the highest 24-hydroxylase activity with 1alpha-hydroxyvitamin D-2 (1alphaOHD(2)) as substrate. The ratio of rates of 24-hydroxylation of 1alpha-hydroxyvitamin D-3 (1alphaOHD(3)), 1alphaOHD(2), and vitamin D-2 by CYP3A4 was 3.6/2.8/1.0. Structures of 24-hydroxyvitamin D-2, 1,24(S)-dihydroxyvitamin D-2, and 1,24-dihydroxyvitamin D-3 were confirmed by HPLC and gas chromatography retention time and mass spectroscopy. In characterized human liver microsomes, 24-hydroxylation of 1alphaOHD(2) by CYP3A4 correlated significantly with 6beta-hydroxylation of testosterone, a marker of CYP3A4 activity. 24-Hydroxylase activity in recombinant CYP3A4 and pooled human liver microsomes showed dose-dependent inhibition by ketoconazole, troleandomycin, alpha-naphthoflavone, and isoniazid, known inhibitors of CYP3A4. Rates of 24- and 25-hydroxylation of 1alphaOHD(2) and 1alphaOHD(3) were determined in recombinant wild-type CYP3A4 and site-directed mutants and naturally occurring variants expressed in Escherichia coli. Substitution of residues showed the most prominent alterations of function at residues 119, 120,301, 305, and 479. Thus, CYP3A4 is both a 24- and 25-hydroxylase for vitamin D-2, 1alphaOHD(2), and 1alphaOHD(3).
引用
收藏
页码:1210 / 1219
页数:10
相关论文
共 42 条
  • [31] Roy P, 1999, DRUG METAB DISPOS, V27, P655
  • [32] Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450
    Sai, Y
    Dai, R
    Yang, TJ
    Krausz, KW
    Gonzalez, FJ
    Gelboin, HV
    Shou, M
    [J]. XENOBIOTICA, 2000, 30 (04) : 327 - 343
  • [33] Dexamethasone in the treatment of subarachnoid hemorrhage, revisited:: a comparative analysis of the effect of the, total dose on complications and outcome
    Schürkämper, M
    Medele, R
    Zausinger, S
    Schmid-Elsaesser, R
    Steiger, HJ
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2004, 11 (01) : 20 - 24
  • [34] Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5)
    Shaw, PM
    Hosea, NA
    Thompson, DV
    Lenius, JM
    Guengerich, FP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 348 (01) : 107 - 115
  • [35] SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
  • [36] MEASUREMENT OF PROTEIN USING BICINCHONINIC ACID
    SMITH, PK
    KROHN, RI
    HERMANSON, GT
    MALLIA, AK
    GARTNER, FH
    PROVENZANO, MD
    FUJIMOTO, EK
    GOEKE, NM
    OLSON, BJ
    KLENK, DC
    [J]. ANALYTICAL BIOCHEMISTRY, 1985, 150 (01) : 76 - 85
  • [37] Stiborová M, 2002, CANCER RES, V62, P5678
  • [38] 1-ALPHA,24(S)-DIHYDROXYVITAMIN D-2 - A BIOLOGICALLY-ACTIVE PRODUCT OF 1-ALPHA-HYDROXYVITAMIN D-2 MADE IN THE HUMAN HEPATOMA, HEP3B
    STRUGNELL, S
    BYFORD, V
    MAKIN, HLJ
    MORIARTY, RM
    GILARDI, R
    LEVAN, LW
    KNUTSON, JC
    BISHOP, CW
    JONES, G
    [J]. BIOCHEMICAL JOURNAL, 1995, 310 : 233 - 241
  • [39] TAU AU, 1997, KIDNEY INT, V51, P583
  • [40] Cooperativity in oxidations catalyzed by cytochrome P450 3A4
    Ueng, YF
    Kuwabara, T
    Chun, YJ
    Guengerich, FP
    [J]. BIOCHEMISTRY, 1997, 36 (02) : 370 - 381